186826-86-8 | 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$6.00	$4.00
50mg	98%	in stock	$7.00	$5.00
250mg	98%	in stock	$12.00	$9.00
1g	98%	in stock	$17.00	$12.00
5g	98%	in stock	$58.00	$41.00
25g	98%	in stock	$122.00	$86.00
100g	98%	in stock	$418.00	$293.00

Description

• Catalog Number: AB46607
• Chemical Name: 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
• CAS Number: 186826-86-8
• Molecular Formula: C21H25ClFN3O4
• Molecular Weight: 437.8923
• MDL Number: MFCD09836237
• SMILES: COc1c(N2C[C@@H]3[C@H](C2)CCCN3)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1.Cl

Computed Properties

• Complexity: 727
• Covalently-Bonded Unit Count: 2
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 30
• Hydrogen Bond Acceptor Count: 8
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 4

Literature

• Observations on conducting whole-cell patch clamping of the hERG cardiac K(+) channel in pure human serum.

  Journal of applied toxicology : JAT 20170401

• Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K(+) Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model.

  Cardiovascular toxicology 20160401

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response.

  The Journal of pharmacology and experimental therapeutics 20140701

• QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation.

  Journal of clinical pharmacology 20140401

• Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.

  Toxicological sciences : an official journal of the Society of Toxicology 20131201

• Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry 20130215

• Development and validation of liquid chromatography-mass spectrometric method for simultaneous determination of moxifloxacin and ketorolac in rat plasma: application to pharmacokinetic study.

  Biomedical chromatography : BMC 20121101

• Identification of a novel resistance mutation in parE that confers high-level resistance to moxifloxacin in Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20121101

• Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study.

  Scandinavian journal of infectious diseases 20121101

• Photodegradation of fluoroquinolones in surface water and antimicrobial activity of the photoproducts.

  Water research 20121101

• In vitro susceptibility of Mycobacterium bovis against moxifloxacin.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20121101

• Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran.

  Internal and emergency medicine 20121001

• Seasonality of Clostridium difficile infections in Southern Germany.

  Epidemiology and infection 20121001

• Fungal keratitis responsive to moxifloxacin monotherapy.

  Cornea 20121001

• Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.

  Clinical therapeutics 20121001

• Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?

  The European respiratory journal 20121001

• 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.

  Lancet (London, England) 20120915

• Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers.

  Journal of clinical pharmacology 20120901

• Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.

  Respiratory medicine 20120901

• Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.

  Diagnostic microbiology and infectious disease 20120901

• Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.

  Clinical therapeutics 20120901

• In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments.

  Rapid communications in mass spectrometry : RCM 20120830

• Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.

  World journal of gastroenterology 20120828

• Characterization of the human QT interval: novel distribution-based assessment of the repolarization effects of moxifloxacin.

  Journal of clinical pharmacology 20120801

• A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.

  International journal of cancer 20120801

• Moxifloxacin punctum plug for sustained drug delivery.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120801

• Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers.

  British journal of clinical pharmacology 20120801

• Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120801

• Anti-inflammatory effects of moxifloxacin on rat airway smooth muscle cells exposed to allergen: Inhibition of extracellular-signal-regulated kinase and nuclear factor-κB activation and of interleukin-8 and eotaxin synthesis.

  Respirology (Carlton, Vic.) 20120801

• In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120801

• Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature.

  Ocular immunology and inflammation 20120801

• Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.

  International journal of clinical pharmacology and therapeutics 20120801

• [Sepsis. Update 2012].

  Deutsche medizinische Wochenschrift (1946) 20120801

• [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany].

  Infection 20120801

• New drug combination for TB is tested in unique trial.

  BMJ (Clinical research ed.) 20120725

• Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.

  Clinical & experimental ophthalmology 20120701

• Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

  The European respiratory journal 20120701

• Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120701

• Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.

  Ophthalmology 20120701

• Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.

  Antimicrobial agents and chemotherapy 20120701

• Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.

  The new microbiologica 20120701

• Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis.

  Expert review of anti-infective therapy 20120701

• Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

  JAMA 20120613

• Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride.

  European journal of drug metabolism and pharmacokinetics 20120601

• Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120601

• Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.

  The European respiratory journal 20120601

• Safety of prophylactic intracameral moxifloxacin use in cataract surgery.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120601

• A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults.

  Cancer chemotherapy and pharmacology 20120601

• Penetration of moxifloxacin into liver tissue.

  International journal of antimicrobial agents 20120601

• Moxifloxacin safety: an analysis of 14 years of clinical data.

  Drugs in R&D 20120601

• In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines.

  Biocontrol science 20120601

• Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120515

• Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120515

• Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.

  Cancer chemotherapy and pharmacology 20120501

• Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.

  The Journal of antibiotics 20120501

• gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.

  The Journal of antimicrobial chemotherapy 20120501

• Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.

  Clinical drug investigation 20120501

• Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.

  Advances in therapy 20120501

• [Evaluation of bacterial colonization of the conjunctival sac in ranibizumab intravitreal injections treated patients].

  Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20120501

• Thorough QT/QTc study of ritonavir-boosted saquinavir following multiple-dose administration of therapeutic and supratherapeutic doses in healthy participants.

  Journal of clinical pharmacology 20120401

• Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia.

  International journal of antimicrobial agents 20120401

• Moxifloxacin versus placebo modeling of the QT interval.

  Journal of pharmacokinetics and pharmacodynamics 20120401

• Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.

  Pharmacotherapy 20120401

• QT effect of semagacestat at therapeutic and supratherapeutic doses.

  International journal of clinical pharmacology and therapeutics 20120401

• Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.

  Emerging infectious diseases 20120401

• Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium.

  Expert review of anti-infective therapy 20120401

• Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.

  Advances in therapy 20120401

• Update on the cardiac safety of moxifloxacin.

  Current drug safety 20120401

• Moxifloxacin-induced hypoglycemia in a non-diabetic patient.

  Current drug safety 20120401

• Trial tests new combination of drugs to treat tuberculosis.

  BMJ (Clinical research ed.) 20120320

• Reevaluation of moxifloxacin pharmacokinetics and their direct effect on the QT interval.

  Journal of clinical pharmacology 20120301

• Pyrazinamide-induced sideroblastic anemia.

  American journal of hematology 20120301

• Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis.

  The European respiratory journal 20120301

• [Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120301

• No evidence of QT prolongation with supratherapeutic doses of aleglitazar.

  Journal of cardiovascular pharmacology 20120301

• Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.

  International journal of antimicrobial agents 20120301

• [In vitro antibiotic susceptibility to fluoroquinolones].

  Archivos de la Sociedad Espanola de Oftalmologia 20120301

• Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.

  American heart journal 20120301

• PanACEA: a new approach to tuberculosis research.

  The Lancet. Infectious diseases 20120301

• Design and evaluation of moxifloxacin hydrochloride ocular inserts.

  Acta pharmaceutica (Zagreb, Croatia) 20120301

• Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

  The Journal of infectious diseases 20120215

• The steroids for corneal ulcers trial: study design and baseline characteristics.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20120201

• Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).

  Archives of ophthalmology (Chicago, Ill. : 1960) 20120201

• Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120201

• Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.

  The Pediatric infectious disease journal 20120201

• Spectrofluorimetric study of the interaction between europium(III) and moxifloxacin in micellar solution and its analytical application.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120201

• Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.

  The Journal of antimicrobial chemotherapy 20120201

• Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.

  International journal of antimicrobial agents 20120201

• Determination of photostability and photodegradation products of moxifloxacin in the presence of metal ions in solutions and solid phase. Kinetics and identification of photoproducts.

  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20120201

• Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery.

  International ophthalmology 20120201

• Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120201

• Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.

  International journal of clinical practice 20120201

• Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120201

• Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120201

• Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.

  British journal of pharmacology 20120101

• Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial.

  The Journal of antimicrobial chemotherapy 20120101

• Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery.

  The Journal of antimicrobial chemotherapy 20120101

• Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.

  Journal of pediatric ophthalmology and strabismus 20120101

• Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.

  Investigative ophthalmology & visual science 20120101

• Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.

  PloS one 20120101

• Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin.

  Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20120101

• Unilateral conjunctival ulcer due to Stenotrophomonas maltophilia infection.

  Indian journal of ophthalmology 20120101

• Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.

  BMC infectious diseases 20120101

• Leukocytoclastic vasculitis induced by Mycoplasma pneumoniae infection.

  Acta dermatovenerologica Croatica : ADC 20120101

• Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions.

  European journal of mass spectrometry (Chichester, England) 20120101

• Good penetration of moxifloxacin into human abscesses.

  Pharmacology 20120101

• Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction.

  Journal of electrocardiology 20120101

• Kinetic and thermodynamic studies of moxifloxacin hydrolysis in the presence and absence of metal ions in acidic solutions.

  Acta poloniae pharmaceutica 20120101

• Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin.

  Toxicology 20111218

• Synthesis, characterization and antimicrobial investigation of some moxifloxacin metal complexes.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111215

• Mycoplasma genitalium: should we treat and how?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111215

• [Development of subcutaneous nodules after mesotherapy].

  Enfermedades infecciosas y microbiologia clinica 20111201

• Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111201

• Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections.

  American journal of ophthalmology 20111201

• Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201

• A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201

• Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.

  Helicobacter 20111201

• In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201

• Simple and rapid liquid chromatography method for determination of moxifloxacin in saliva.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115

• A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.

  The Journal of antimicrobial chemotherapy 20111101

• Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.

  Clinical drug investigation 20111101

• Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis.

  The Annals of pharmacotherapy 20111101

• Alcaligenes xylosoxidans contact lens-related keratitis--a case report and literature review.

  Eye & contact lens 20111101

• Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes.

  Retina (Philadelphia, Pa.) 20111101

• Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience.

  The European respiratory journal 20111001

• Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent.

  European journal of pediatrics 20111001

• Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication.

  Journal of medical microbiology 20111001

• Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.

  The Journal of antimicrobial chemotherapy 20111001

• Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model.

  The Journal of antimicrobial chemotherapy 20111001

• Multidrug resistance in European Clostridium difficile clinical isolates.

  The Journal of antimicrobial chemotherapy 20111001

• Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.

  Ocular immunology and inflammation 20111001

• Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.

  Ocular immunology and inflammation 20111001

• Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001

• Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.

  Ophthalmology 20111001

• A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin.

  Korean journal of ophthalmology : KJO 20111001

• Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.

  Archives of pharmacal research 20111001

• Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.

  The British journal of ophthalmology 20110901

• Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.

  Journal of periodontology 20110901

• Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.

  International journal of antimicrobial agents 20110901

• The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil.

  Clinical pharmacology and therapeutics 20110901

• Moxifloxacin-dependent Torsades de Pointes.

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110901

• Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110901

• [The effect of moxifloxacin on apoptosis of airway smooth muscle cells and mitochondria membrane potential].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20110901

• Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies.

  Journal of clinical pharmacology 20110801

• Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.

  Anaerobe 20110801

• Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones.

  Bioorganic & medicinal chemistry letters 20110801

• Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.

  AJR. American journal of roentgenology 20110801

• [Current value of quinolones in Helicobacter pylori therapy].

  Zeitschrift fur Gastroenterologie 20110801

• The TB Alliance: overcoming challenges to chart the future course of TB drug development.

  Future medicinal chemistry 20110801

• Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110701

• Creation of a knowledge management system for QT analyses.

  Journal of clinical pharmacology 20110701

• Interface blood after descemet stripping automated endothelial keratoplasty.

  Cornea 20110701

• T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.

  Heart rhythm 20110701

• Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections.

  Ophthalmology 20110701

• Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.

  Advances in therapy 20110701

• Interaction study of moxifloxacin and lomefloxacin with co-administered drugs.

  Pakistan journal of pharmaceutical sciences 20110701

• A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.

  Clinical therapeutics 20110701

• [The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection].

  Voenno-meditsinskii zhurnal 20110701

• Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.

  The Medical journal of Australia 20110606

• Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost.

  Journal of clinical pharmacology 20110601

• Aclidinium bromide, a long-acting antimuscarinic, does not affect QT interval in healthy subjects.

  Journal of clinical pharmacology 20110601

• Preventing endophthalmitis after cataract surgeries.

  The British journal of ophthalmology 20110601

• Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.

  International journal of antimicrobial agents 20110601

• Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis.

  Therapeutic drug monitoring 20110601

• Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.

  Journal of cataract and refractive surgery 20110601

• Intravenous moxifloxacin. Even more harmful than the oral form.

  Prescrire international 20110601

• Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.

  The Korean journal of internal medicine 20110601

• Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.

  Journal of chemotherapy (Florence, Italy) 20110601

• Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans.

  Medical mycology 20110501

• Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design.

  The Journal of antimicrobial chemotherapy 20110501

• Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110501

• Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110501

• IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone.

  International immunopharmacology 20110401

• Radiosynthesis and biological evaluation of the (99m)Tc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110401

• Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.

  International journal of antimicrobial agents 20110401

• In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride.

  The Journal of antimicrobial chemotherapy 20110401

• Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis.

  Helicobacter 20110401

• Rational use of moxifloxacin for tuberculosis treatment.

  The Lancet. Infectious diseases 20110401

• Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20110401

• Mycobacterium bolletii/Mycobacterium massiliense furunculosis associated with pedicure footbaths: a report of 3 cases.

  Archives of dermatology 20110401

• [Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401

• Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.

  Future microbiology 20110401

• Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20110401

• Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases.

  Die Pharmazie 20110401

• Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.

  Investigative ophthalmology & visual science 20110325

• [Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation].

  Revue medicale suisse 20110316

• Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines.

  Bioorganic & medicinal chemistry letters 20110315

• High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.

  Analytical chemistry 20110315

• Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009.

  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20110310

• Perioperative moxifloxacin treatment in rats subjected to deep hypothermic circulatory arrest: reduction in cerebral inflammation but without improvement in cognitive performance.

  The Journal of thoracic and cardiovascular surgery 20110301

• Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.

  The Journal of antimicrobial chemotherapy 20110301

• Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.

  The Journal of antimicrobial chemotherapy 20110301

• Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia.

  The Journal of infection 20110301

• Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110301

• Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses.

  American journal of veterinary research 20110301

• Torticollis in mice intravenously infected with Mycobacterium tuberculosis.

  Journal of the American Association for Laboratory Animal Science : JAALAS 20110301

• In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones.

  Allergy 20110201

• Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.

  European journal of clinical pharmacology 20110201

• Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.

  FEMS immunology and medical microbiology 20110201

• Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

  Dermatology (Basel, Switzerland) 20110201

• Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study.

  Helicobacter 20110201

• Surface layer protein A variant of Clostridium difficile PCR-ribotype 027.

  Emerging infectious diseases 20110201

• Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin.

  Veterinary microbiology 20110110

• Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.

  Investigative ophthalmology & visual science 20110105

• Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection.

  Shock (Augusta, Ga.) 20110101

• Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.

  European journal of clinical pharmacology 20110101

• Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis.

  Journal of periodontology 20110101

• Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.

  Cornea 20110101

• Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

  Drugs 20110101

• Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.

  Journal of gastroenterology and hepatology 20110101

• Relevance of aqueous humor concentrations of fluoroquinolones.

  Journal of cataract and refractive surgery 20110101

• Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20110101

• Vitreous and aqueous penetration of orally and topically administered moxifloxacin.

  Ophthalmic research 20110101

• [Highlights of the Congress of the National Infectious Disease Medicine Days 2010].

  Medecine et maladies infectieuses 20110101

• Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis.

  Retina (Philadelphia, Pa.) 20110101

• Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.

  Journal of pharmacological and toxicological methods 20110101

• The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

  Clinical drug investigation 20110101

• Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study.

  BMC pulmonary medicine 20110101

• Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system.

  mBio 20110101

• A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

  International journal of chronic obstructive pulmonary disease 20110101

• The thorough QT study: let's be precise.

  Cardiology journal 20110101

• Improving the precision of QT measurements.

  Cardiology journal 20110101

• A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress.

  PloS one 20110101

• Moxifloxacin-induced delirium with hallucinations.

  Psychosomatics 20110101

• Rhodococcus equi infection after reduction mammaplasty in an immunocompetent patient.

  Revista do Instituto de Medicina Tropical de Sao Paulo 20110101

• Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.

  BMC structural biology 20110101

• Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.

  International journal of immunopathology and pharmacology 20110101

• Investigation of parameters highlighting drug induced small changes of the T-wave's morphology for drug safety studies.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101

• [Present and future in the use of anti-tubercular drugs].

  Pneumologia (Bucharest, Romania) 20110101

• High performance liquid chromatography assay with ultraviolet detection for moxifloxacin: validation and application to a pharmacokinetic study in Chinese volunteers.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101215

• Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101201

• Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

• Can intraocular lenses deliver antibiotics intracamerally?

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201

• Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.

  Journal of cataract and refractive surgery 20101201

• Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.

  Current eye research 20101201

• Half-century-old TB drugs get a facelift in new cocktails.

  Nature medicine 20101201

• [Chinfloxacin hydrochloride inhibits HERG potassium channel at open state].

  Yao xue xue bao = Acta pharmaceutica Sinica 20101201

• Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.

  Journal of clinical pharmacology 20101101

• Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies.

  Journal of clinical pharmacology 20101101

• In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101

• Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.

  Cornea 20101101

• Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.

  BJOG : an international journal of obstetrics and gynaecology 20101101

• Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.

  American journal of ophthalmology 20101101

• Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.

  Eye & contact lens 20101101

• Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin.

  Pediatrics 20101101

• Fluoroquinolones in the management of community-acquired pneumonia in primary care.

  Expert review of anti-infective therapy 20101101

• [Use of moxifloxacin in tuberculosis regimen in a French teaching hospital].

  Medecine et maladies infectieuses 20101001

• Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections.

  Surgical infections 20101001

• Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia.

  International journal of antimicrobial agents 20101001

• Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding.

  Expert opinion on pharmacotherapy 20101001

• Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

  Clinical pharmacology and therapeutics 20101001

• Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20101001

• Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001

• [The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis].

  Archivos de la Sociedad Espanola de Oftalmologia 20101001

• An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100915

• Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.

  Acta oto-laryngologica 20100901

• Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.

  Journal of cataract and refractive surgery 20100901

• Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.

  Japanese journal of ophthalmology 20100901

• Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers.

  Acta pharmaceutica (Zagreb, Croatia) 20100901

• [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20100801

• Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.

  Research in veterinary science 20100801

• Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.

  Pulmonary pharmacology & therapeutics 20100801

• Colonisation of fluoroquinolone-resistant Haemophilus influenzae among nursing home residents in southern Taiwan.

  The Journal of hospital infection 20100801

• Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

  Eye (London, England) 20100801

• Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.

  International journal of antimicrobial agents 20100801

• Oritavancin, a new lipoglycopeptide antibiotic: results from a thorough QT study.

  Journal of clinical pharmacology 20100801

• Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing.

  European journal of clinical pharmacology 20100801

• Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

  The Journal of antimicrobial chemotherapy 20100801

• Antibiotic resistance of subgingival species in chronic periodontitis patients.

  Journal of periodontal research 20100801

• Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.

  International journal of oncology 20100801

• Electrochemical determination of gatifloxacin, moxifloxacin and sparfloxacin fluoroquinolonic antibiotics on glassy carbon electrode in pharmaceutical formulations.

  Drug testing and analysis 20100801

• A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100801

• Doxycycline failure in lymphogranuloma venereum.

  Sexually transmitted infections 20100801

• Severe corneal changes following intravitreal injection of bevacizumab.

  Ocular immunology and inflammation 20100801

• Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.

  Journal of chemotherapy (Florence, Italy) 20100801

• Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp.

  Journal of chemotherapy (Florence, Italy) 20100801

• Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100801

• [Mutant prevention concentrations of garenoxacin against Streptococcus pneumoniae isolates from otorhinolaryngological infections].

  The Japanese journal of antibiotics 20100801

• [R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].

  Medecine et maladies infectieuses 20100701

• Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials.

  International journal of antimicrobial agents 20100701

• Comparison of pharmacokinetic profiles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection.

  Combinatorial chemistry & high throughput screening 20100701

• Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.

  Clinical pharmacology and therapeutics 20100701

• Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.

  Cornea 20100701

• Spontaneous subconjunctival abscess because of Haemophilus influenzae.

  Cornea 20100701

• Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.

  Wiener klinische Wochenschrift 20100701

• Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects.

  British journal of clinical pharmacology 20100701

• Fungal keratitis associated with ocular rosacea.

  International ophthalmology 20100601

• A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy.

  Anaerobe 20100601

• Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.

  Research in veterinary science 20100601

• Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock.

  Intensive care medicine 20100601

• In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.

  Antimicrobial agents and chemotherapy 20100601

• Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601

• Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.

  The journal of obstetrics and gynaecology research 20100601

• Tsukamurella: an emerging opportunistic ocular pathogen.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20100601

• Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs.

  Analytica chimica acta 20100514

• Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells.

  Eye (London, England) 20100501

• Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles.

  Journal of pharmaceutical and biomedical analysis 20100501

• Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.

  Journal of clinical pharmacology 20100501

• Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.

  Clinical pharmacology and therapeutics 20100501

• Statistical characteristics of moxifloxacin-induced QTc effect.

  Journal of biopharmaceutical statistics 20100501

• Statistical consideration in testing for assay sensitivity in a 'thorough' QT study.

  Journal of biopharmaceutical statistics 20100501

• Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials.

  Journal of biopharmaceutical statistics 20100501

• Response to letter to the editor: Statistical issues of QT prolongation assessment based on linear concentration modeling by Yi Tsong et al.

  Journal of biopharmaceutical statistics 20100501

• Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.

  Emerging infectious diseases 20100501

• Thorough QT study of the effect of fesoterodine on cardiac repolarization.

  International journal of clinical pharmacology and therapeutics 20100501

• Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.

  The Laryngoscope 20100501

• Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.

  American journal of veterinary research 20100501

• Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.

  Journal of cataract and refractive surgery 20100501

• Comparing the effectiveness of moxifloxacin and povidone-iodine with povidone-iodine alone.

  Journal of cataract and refractive surgery 20100501

• Inguinal panniculitis in a young Tasmanian devil (Sarcophilus harrisii) caused by Mycobacterium mageritense.

  Australian veterinary journal 20100501

• [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20100501

• Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates.

  Carbohydrate research 20100419

• Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors.

  Biochemical pharmacology 20100415

• Bacterial contamination of the vitreous cavity associated with transconjunctival 25-gauge microincision vitrectomy surgery.

  Ophthalmology 20100401

• Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.

  Paediatric drugs 20100401

• [Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis].

  Journal francais d'ophtalmologie 20100401

• Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.

  Diagnostic microbiology and infectious disease 20100401

• Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.

  The Annals of pharmacotherapy 20100401

• Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401

• Red eye, blurry vision, and cough.

  The Journal of family practice 20100401

• Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.

  British journal of clinical pharmacology 20100401

• Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method.

  Journal of analytical toxicology 20100401

• [Fatal acute hepatitis and cholestasis associated with liver disease].

  Medicina clinica 20100320

• Update in tuberculosis 2009.

  American journal of respiratory and critical care medicine 20100315

• Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium.

  Archives of toxicology 20100301

• Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death.

  The Journal of antimicrobial chemotherapy 20100301

• A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease.

  International journal of STD & AIDS 20100301

• Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100201

• Synthesis and evaluation of (99m)Tc-moxifloxacin, a potential infection specific imaging agent.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20100201

• Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.

  Current medical research and opinion 20100201

• Activity of various drugs alone or in combination against Mycobacterium fortuitum.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100201

• Simultaneous scrofuloderma and intracranial tuberculomas: a rare presentation of systemic tuberculosis.

  The Australasian journal of dermatology 20100201

• Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis.

  Journal of periodontology 20100201

• [Efficacy of second-line treatment based on moxifloxacin triple therapy for Helicobacter pylori infection].

  Zhonghua yi xue za zhi 20100112

• [Efficacy of moxifloxacin-based triple therapy to eradicate Helicobacter pylori infection].

  Zhonghua yi xue za zhi 20100112

• In vitro elution of moxifloxacin from cancellous bone allografts.

  Journal of biomedical materials research. Part A 20100101

• Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.

  Eye (London, England) 20100101

• Use of a mydriatic cocktail with a wick for preoperative mydriasis in cataract surgery: a prospective randomised controlled trial.

  Eye (London, England) 20100101

• Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101

• Moxifloxacin associated vanishing bile duct syndrome.

  Journal of clinical gastroenterology 20100101

• Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).

  British journal of pharmacology 20100101

• Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis.

  Journal of medical microbiology 20100101

• The use of baseline covariates in crossover studies.

  Biostatistics (Oxford, England) 20100101

• Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100101

• A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers.

  American journal of therapeutics 20100101

• Besifloxacin ophthalmic suspension 0.6%.

  Drugs 20100101

• Systemic anaphylaxis caused by moxifloxacin.

  Allergologia et immunopathologia 20100101

• Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.

  Journal of pharmacological and toxicological methods 20100101

• Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

  Respiratory research 20100101

• Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.

  Canadian journal of microbiology 20100101

• Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.

  Advances in therapy 20100101

• Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations.

  Chemotherapy 20100101

• Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study.

  Clinical drug investigation 20100101

• Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.

  Annals of clinical microbiology and antimicrobials 20100101

• Prulifloxacin ECG study.

  Clinical drug investigation 20100101

• [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].

  Mikrobiyoloji bulteni 20100101

• Legionnaires' disease mimicking swine influenza (H1N1) pneumonia during the 'herald wave' of the pandemic.

  Heart & lung : the journal of critical care 20100101

• Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals.

  Journal of pharmacological and toxicological methods 20100101

• Bile and gallbladder tissue concentrations of moxifloxacin in patients with acute cholecystitis.

  The Annals of pharmacotherapy 20100101

• [Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age].

  Medycyna doswiadczalna i mikrobiologia 20100101

• Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.

  Clinical drug investigation 20100101

• Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.

  Journal of pharmacological and toxicological methods 20100101

• Biopsy proven acute interstitial nephritis after treatment with moxifloxacin.

  BMC nephrology 20100101

• The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model.

  mBio 20100101

• Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.

  Chemotherapy 20100101

• A role for spleen monocytes in post-ischemic brain inflammation and injury.

  Journal of neuroinflammation 20100101

• [Moxifloxacin and hepatic toxicity].

  Gastroenterologia y hepatologia 20091201

• In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20091201

• Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.

  Research in microbiology 20091201

• Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.

  Anaerobe 20091201

• Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

  Eye (London, England) 20091201

• Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091201

• Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.

  Therapeutic advances in respiratory disease 20091201

• Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals.

  Expert opinion on investigational drugs 20091201

• Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac.

  Journal of cataract and refractive surgery 20091201

• Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201

• Effect of cefuroxime and moxifloxacin on Staphylococcus epidermidis adherence to intraocular lenses.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20091201

• Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: pharmacokinetic- pharmacodynamic evaluation of sunitinib.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091115

• Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies.

  Clinical pharmacology and therapeutics 20091101

• Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD.

  The European respiratory journal 20091101

• Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.

  International journal of antimicrobial agents 20091101

• Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.

  International journal of antimicrobial agents 20091101

• Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.

  The Journal of antimicrobial chemotherapy 20091101

• Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes.

  Journal of clinical pharmacology 20091101

• Abuse of antibiotic prophylaxis in third molar surgeries.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091101

• Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.

  Journal of drugs in dermatology : JDD 20091101

• Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.

  Current medical research and opinion 20091001

• Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.

  The Journal of hospital infection 20091001

• Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091001

• Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.

  Cornea 20091001

• Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis.

  Expert opinion on pharmacotherapy 20091001

• Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.

  Helicobacter 20091001

• Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?

  American journal of respiratory and critical care medicine 20091001

• Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections.

  Infection 20091001

• One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.

  Journal of cataract and refractive surgery 20091001

• A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.

  International journal of STD & AIDS 20091001

• Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.

  Prescrire international 20091001

• Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.

  Prescrire international 20091001

• Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC.

  Journal of pharmaceutical and biomedical analysis 20090908

• Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.

  International journal of antimicrobial agents 20090901

• Antibacterial activity of lipophilic fluoroquinolone derivatives.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20090901

• Efficacy of fluoroquinolones against pathogenic oral bacteria.

  Mini reviews in medicinal chemistry 20090901

• Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model.

  The Journal of antimicrobial chemotherapy 20090901

• Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.

  Ophthalmology 20090901

• Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

  American journal of respiratory and critical care medicine 20090801

• Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.

  The Journal of antimicrobial chemotherapy 20090801

• Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.

  The Journal of antimicrobial chemotherapy 20090801

• Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801

• Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations.

  Journal of clinical pharmacology 20090801

• A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.

  Journal of clinical pharmacology 20090801

• Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.

  Anesthesia and analgesia 20090801

• Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801

• Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.

  The American journal of the medical sciences 20090801

• 10 years' experience with the pneumococcal quinolone moxifloxacin.

  Expert review of anti-infective therapy 20090801

• Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20090801

• Haemolytic anaemia following rituximab treatment in a patient with pemphigus vulgaris.

  The British journal of dermatology 20090701

• [Successful treatment of Legionella pneumonia with moxifloxacin in a hemodialysis patient].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090701

• Moxifloxacin versus ethambutol in initial tuberculosis treatment.

  Lancet (London, England) 20090627

• Moxifloxacin versus ethambutol in initial tuberculosis treatment.

  Lancet (London, England) 20090627

• Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep.

  Veterinary journal (London, England : 1997) 20090601

• Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601

• Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects.

  Journal of clinical pharmacology 20090601

• Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090601

• Late-onset laser in situ keratomileusis-related corneal ulcer--a case series.

  Cornea 20090601

• Intracameral moxifloxacin: in vitro safety on human ocular cells.

  Cornea 20090601

• Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases.

  Nature structural & molecular biology 20090601

• Electrocardiographic QTc changes due to moxifloxacin infusion.

  Journal of clinical pharmacology 20090601

• [A case of primary pulmonary nocardiosis with multiple pulmonary nodules successfully treated with moxifloxacin].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090601

• Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.

  Leprosy review 20090601

• Trimethoprim/sulfamethoxazole resistance in urinary tract infections.

  The Journal of emergency medicine 20090501

• Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.

  The Journal of antimicrobial chemotherapy 20090501

• Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested.

  Journal of clinical pharmacology 20090501

• Deferasirox does not induce QT/QTc-prolongation in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20090501

• Severe and symptomatic hyponatraemia after moxifloxacin intake.

  The Netherlands journal of medicine 20090501

• Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415

• 'My foot hurts': a flare of rheumatoid arthritis?

  The Medical journal of Australia 20090406

• Fourth-generation fluoroquinolones in tuberculosis.

  Lancet (London, England) 20090404

• Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

  Lancet (London, England) 20090404

• Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.

  International journal of antimicrobial agents 20090401

• Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.

  Antimicrobial agents and chemotherapy 20090401

• The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells.

  Free radical research 20090401

• Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090401

• Stability of extemporaneously prepared moxifloxacin oral suspensions.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090401

• Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.

  Advances in therapy 20090401

• Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis.

  Journal of chemotherapy (Florence, Italy) 20090401

• Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

  Journal of chemotherapy (Florence, Italy) 20090401

• Mycobacterium chelonae infection in a tattoo site.

  The Medical journal of Australia 20090302

• High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.

  The Journal of infection 20090301

• Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study.

  Journal of clinical pharmacology 20090301

• Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones.

  Journal of cataract and refractive surgery 20090301

• Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions.

  Xenobiotica; the fate of foreign compounds in biological systems 20090301

• Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens.

  British poultry science 20090301

• Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study.

  International journal of antimicrobial agents 20090201

• Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.

  Therapeutic drug monitoring 20090201

• Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.

  The Journal of antimicrobial chemotherapy 20090201

• Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090201

• Fluoroquinolones and postoperative endophthalmitis.

  Journal of cataract and refractive surgery 20090201

• Fluoroquinolones and postoperative endophthalmitis.

  Journal of cataract and refractive surgery 20090201

• Influence of type and neutralisation capacity of antacids on dissolution rate of ciprofloxacin and moxifloxacin from tablets.

  Bosnian journal of basic medical sciences 20090201

• Treatment of extensively drug-resistant tuberculosis.

  Lancet (London, England) 20090103

• Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090101

• Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).

  International journal of antimicrobial agents 20090101

• Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).

  International journal of antimicrobial agents 20090101

• Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.

  Scandinavian journal of infectious diseases 20090101

• Cerebrospinal fluid of patients administered moxifloxacin modulates the secretion of cytokines from human monocytes.

  Diagnostic microbiology and infectious disease 20090101

• Severe pseudomembranous colitis after moxifloxacin use: a case series.

  The Annals of pharmacotherapy 20090101

• The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.

  Cornea 20090101

• Automated QT measurement and application to detection of moxifloxacin-induced changes.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101

• ECG evaluation of ventricular properties: the importance of cardiac cycle length.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101

• Automated QT analysis that learns from cardiologist annotations.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101

• Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.

  Wiener klinische Wochenschrift 20090101

• Acute generalized exanthematous pustulosis following oral treatment with moxifloxacine.

  European journal of dermatology : EJD 20090101

• Aspergillus iris granuloma: a case report with review of literature.

  Survey of ophthalmology 20090101

• Penetration of moxifloxacin into rat mandibular bone and soft tissue.

  Acta odontologica Scandinavica 20090101

• Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling.

  Clinical pharmacokinetics 20090101

• Extensively drug resistance (XDR) tb is not always fatal.

  The Indian journal of tuberculosis 20090101

• Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes.

  Drug safety 20090101

• Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing.

  Journal of pharmacological and toxicological methods 20090101

• [Conjunctivitis due to Achromobacter xylosoxidans: case report].

  Arquivos brasileiros de oftalmologia 20090101

• Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.

  Ophthalmic research 20090101

• [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

  American journal of therapeutics 20090101

• [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo].

  Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20090101

• Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101

• Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis.

  Heart & lung : the journal of critical care 20090101

• Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101

• Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials.

  Internal medicine (Tokyo, Japan) 20090101

• [Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.

  Digestive diseases and sciences 20081201

• In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan).

  International journal of antimicrobial agents 20081201

• Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes.

  Acta pharmacologica Sinica 20081201

• A comparison of fluoroquinolone penetration into human conjunctival tissue.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201

• Extensively drug-resistant tuberculosis.

  The New England journal of medicine 20081127

• Disposition kinetics of moxifloxacin in lactating ewes.

  Veterinary journal (London, England : 1997) 20081101

• Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine.

  Clinical pharmacology and therapeutics 20081101

• Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study.

  Biomedical chromatography : BMC 20081101

• [Severe febrile illness with renal impairment after travel to Southeast Asia].

  Der Internist 20081101

• Disseminated salmonellosis in a patient treated with temozolomide.

  The Journal of infection 20081101

• Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?

  American journal of respiratory and critical care medicine 20081101

• Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells.

  Current eye research 20081101

• Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.

  Clinical therapeutics 20081101

• Facilitated permeation of antibiotics across membrane channels--interaction of the quinolone moxifloxacin with the OmpF channel.

  Journal of the American Chemical Society 20081008

• Eikenella corrodens as a causative agent for neonatal conjunctivitis.

  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20081001

• Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20081001

• Antimicrobial activity of acrylic intraocular lenses soaked in fourth generation fluoroquinolones.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001

• Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study.

  International journal of STD & AIDS 20081001

• Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis.

  Journal of periodontology 20081001

• Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.

  Advances in therapy 20081001

• The effect of moxifloxacin on QTc and implications for the design of thorough QT studies.

  Clinical pharmacology and therapeutics 20081001

• Moxifloxacin monotherapy in severe pneumonia: do we really need it?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080915

• Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080901

• Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.

  The Journal of antimicrobial chemotherapy 20080901

• Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.

  The Journal of antimicrobial chemotherapy 20080901

• Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

  British journal of clinical pharmacology 20080901

• Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin.

  International journal of clinical practice 20080901

• Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.

  Journal of cataract and refractive surgery 20080901

• Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.

  Journal of cataract and refractive surgery 20080901

• Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells.

  Cornea 20080901

• Biofilm formation is not necessary for development of quinolone-resistant 'persister' cells in an attached Staphylococcus epidermidis population.

  The International journal of artificial organs 20080901

• [Novel side effects of moxifloxacin: making a balanced decision again].

  Nederlands tijdschrift voor geneeskunde 20080823

• Penetration and accumulation of moxifloxacin in uterine tissue.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20080801

• Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?

  International journal of antimicrobial agents 20080801

• A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment.

  Contact lens & anterior eye : the journal of the British Contact Lens Association 20080801

• Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability.

  British journal of pharmacology 20080801

• Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.

  Journal of cataract and refractive surgery 20080801

• Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora.

  Journal of cataract and refractive surgery 20080801

• Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a one-day or one-hour application.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801

• Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.

  Journal of drugs in dermatology : JDD 20080801

• Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080801

• Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.

  The Journal of antimicrobial chemotherapy 20080701

• Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects.

  Journal of clinical pharmacology 20080701

• In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.

  International journal of antimicrobial agents 20080701

• Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.

  The Journal of infection 20080701

• A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin.

  Expert opinion on pharmacotherapy 20080701

• Moxifloxacin: a respiratory fluoroquinolone.

  Expert opinion on pharmacotherapy 20080701

• Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery.

  Journal of cataract and refractive surgery 20080701

• Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature.

  International journal of surgical pathology 20080701

• A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve.

  Heart and vessels 20080701

• Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect.

  The Journal of antimicrobial chemotherapy 20080601

• Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.

  Journal of clinical pharmacology 20080601

• Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers.

  The Annals of pharmacotherapy 20080601

• Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones.

  The British journal of ophthalmology 20080601

• Moxifloxacin for bacterial keratitis.

  Ophthalmology 20080601

• [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].

  Biomedica : revista del Instituto Nacional de Salud 20080601

• In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.

  World journal of gastroenterology 20080528

• Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080515

• Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.

  Diagnostic microbiology and infectious disease 20080501

• A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.

  Current medical research and opinion 20080501

• Interactions between warfarin and three commonly prescribed fluoroquinolones.

  The Annals of pharmacotherapy 20080501

• Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin.

  Southern medical journal 20080501

• Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin.

  Acta neurochirurgica 20080501

• Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.

  Journal of cataract and refractive surgery 20080501

• Minimising moxifloxacin resistance with tuberculosis.

  The Lancet. Infectious diseases 20080501

• Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.

  Clinical & experimental ophthalmology 20080501

• Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach.

  Biophysical journal 20080415

• Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.

  British journal of clinical pharmacology 20080401

• Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.

  The Annals of pharmacotherapy 20080401

• Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.

  Journal of medical microbiology 20080401

• Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.

  Cornea 20080401

• Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080325

• Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.

  Biochemical pharmacology 20080315

• Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure.

  Diagnostic microbiology and infectious disease 20080301

• Deep infection of a total knee implant as a complication of disseminated pneumococcal sepsis. A case report and review of literature.

  The Knee 20080301

• Does in vitro susceptibility predict clinical outcome in bacterial keratitis?

  American journal of ophthalmology 20080301

• A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.

  Current medical research and opinion 20080301

• Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis.

  The Journal of antimicrobial chemotherapy 20080301

• In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment.

  Journal of cataract and refractive surgery 20080301

• Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea.

  Optometry (St. Louis, Mo.) 20080301

• In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin.

  Eye & contact lens 20080301

• Vitreal penetration of oral moxifloxacin in humans.

  Retina (Philadelphia, Pa.) 20080301

• A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

  Current medical research and opinion 20080301

• Moxifloxacin.

  Tuberculosis (Edinburgh, Scotland) 20080301

• Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080201

• In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.

  Diagnostic microbiology and infectious disease 20080201

• Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.

  Anaerobe 20080201

• Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.

  The Journal of infection 20080201

• Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.

  International journal of antimicrobial agents 20080201

• Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells.

  Current medical research and opinion 20080201

• One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.

  Helicobacter 20080201

• Late-onset interface inflammation associated with wearing cosmetic lenses 18 months after laser in situ keratomileusis.

  Cornea 20080201

• A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080201

• Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.

  Infection 20080201

• Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.

  Journal of cataract and refractive surgery 20080201

• Endophthalmitis.

  Ophthalmology 20080201

• Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique.

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20080201

• Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.

  Clinical therapeutics 20080201

• Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?

  Journal of chemotherapy (Florence, Italy) 20080201

• Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis.

  Journal of chemotherapy (Florence, Italy) 20080201

• Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201

• Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.

  Clinical pharmacology and therapeutics 20080101

• Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D.

  The Journal of antimicrobial chemotherapy 20080101

• Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.

  International journal of antimicrobial agents 20080101

• Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.

  The Journal of pharmacy and pharmacology 20080101

• Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.

  Drug safety 20080101

• Promising results for new tuberculosis therapy.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080101

• Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080101

• Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.

  Eye & contact lens 20080101

• Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries.

  Respirology (Carlton, Vic.) 20080101

• Primary photophysical properties of moxifloxacin--a fluoroquinolone antibiotic.

  Photochemistry and photobiology 20080101

• Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.

  Clinical drug investigation 20080101

• Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis.

  Ophthalmic research 20080101

• Early bacterial keratitis after presbyopic LASIK.

  Cornea 20080101

• Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.

  Drug safety 20080101

• Moxifloxacin-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis.

  Journal of investigational allergology & clinical immunology 20080101

• A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.

  Journal of biopharmaceutical statistics 20080101

• Validation testing in thorough QT/QTc clinical trials.

  Journal of biopharmaceutical statistics 20080101

• Statistical issues of QT prolongation assessment based on linear concentration modeling.

  Journal of biopharmaceutical statistics 20080101

• Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.

  PloS one 20080101

• Fluoroquinolone resistance during 2000-2005: an observational study.

  BMC infectious diseases 20080101

• Severe acute polyarthritis in a child after high doses of moxifloxacin.

  Scandinavian journal of infectious diseases 20080101

• Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.

  Polish journal of microbiology 20080101

• Moxifloxacin-induced torsades de pointes.

  Cardiology journal 20080101

• A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.

  Japanese journal of ophthalmology 20080101

• Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration.

  Retina (Philadelphia, Pa.) 20080101

• [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].

  Annales de dermatologie et de venereologie 20080101

• Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis.

  Journal of pediatric ophthalmology and strabismus 20080101

• A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.

  Journal of pediatric ophthalmology and strabismus 20080101

• The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy.

  Veterinary ophthalmology 20080101

• [Unwanted side effects of antibacterials--a diagnostic challenge].

  Deutsche medizinische Wochenschrift (1946) 20080101

• Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.

  International journal of pharmaceutics 20071210

• The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.

  British journal of clinical pharmacology 20071201

• Ocular cysticercosis of the anterior segment.

  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20071201

• Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

  Rheumatology (Oxford, England) 20071201

• Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.

  Current medical research and opinion 20071201

• Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.

  Journal of veterinary pharmacology and therapeutics 20071201

• Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide.

  Peptides 20071201

• Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201

• Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.

  Helicobacter 20071201

• A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.

  Infection 20071201

• Nosocomial pneumonia - are economical considerations important?

  Infection 20071201

• Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus.

  Cornea 20071201

• Electroconvulsive therapy and antibiotics: a case report.

  The journal of ECT 20071201

• Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.

  PLoS medicine 20071201

• Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis.

  Clinical therapeutics 20071201

• Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.

  Journal of chemotherapy (Florence, Italy) 20071201

• Ototoxicity of topical moxifloxacin in a chinchilla animal model.

  The Laryngoscope 20071201

• Infectious keratitis secondary to Histoplasma capsulatum: the first case reports in humans.

  The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20071201

• Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.

  International journal of antimicrobial agents 20071101

• In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.

  The Journal of antimicrobial chemotherapy 20071101

• Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study.

  European journal of clinical pharmacology 20071101

• [In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci].

  Pathologie-biologie 20071101

• The increasing problem of antibiotic resistance.

  Journal of cataract and refractive surgery 20071101

• Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.

  Journal of cataract and refractive surgery 20071101

• In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas.

  Die Pharmazie 20071101

• Doctors report breakthrough antibiotic treatment for TB.

  The AIDS reader 20071101

• Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives.

  Bioorganic & medicinal chemistry letters 20071015

• Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20071015

• Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20071001

• Emergency department drug orders: does drug storage location make a difference?

  Annals of emergency medicine 20071001

• Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population.

  Helicobacter 20071001

• Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.

  Oral microbiology and immunology 20071001

• Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis.

  Journal of veterinary pharmacology and therapeutics 20071001

• Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.

  Journal of cataract and refractive surgery 20071001

• Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071001

• Drug combo speeds up TB treatment.

  AIDS patient care and STDs 20071001

• Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20071001

• [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

  Der Urologe. Ausg. A 20070901

• Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

  Eye (London, England) 20070901

• Treatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in China.

  International journal of clinical practice 20070901

• Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis.

  Current medical research and opinion 20070901

• Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

  Ophthalmology 20070901

• Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.

  The Canadian journal of cardiology 20070901

• Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.

  International journal of chronic obstructive pulmonary disease 20070901

• Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom.

  Ophthalmology 20070801

• Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.

  The Journal of antimicrobial chemotherapy 20070801

• Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.

  Antimicrobial agents and chemotherapy 20070801

• Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.

  American journal of ophthalmology 20070801

• Fourth-generation fluoroquinolone-resistant bacterial keratitis.

  Journal of cataract and refractive surgery 20070801

• [Abstracts of the 6th Moxifloxacin Research Workshop, March 1-2, 2007, Leverkusen, Germany].

  Infection 20070801

• Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.

  Eye (London, England) 20070701

• Cross-over assessment of serum bactericidal activity of moxifloxacin and levofloxacin versus penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in healthy volunteers.

  Diagnostic microbiology and infectious disease 20070701

• Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.

  Cornea 20070701

• [Brochiectasis (in the adult)].

  Praxis 20070613

• Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.

  Journal of cardiovascular electrophysiology 20070601

• Effect of fourth-generation fluoroquinolones on the healing rate of corneal erosions in an animal model.

  Cornea 20070601

• Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.

  Cornea 20070601

• The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.

  Current medical research and opinion 20070601

• Nocardia farcinica brain abscess in a patient without immunocompromise.

  British journal of neurosurgery 20070601

• A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).

  Clinical interventions in aging 20070601

• In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.

  Ophthalmology 20070501

• In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces.

  Journal of endodontics 20070501

• Central venous catheter-related Streptomyces septic thrombosis.

  Infection control and hospital epidemiology 20070501

• Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.

  Eye & contact lens 20070501

• [Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070501

• The influence of fluoroquinolone drugs on the bacterial growth of S. epidermidis utilizing the unique potential of vibrational spectroscopy.

  The journal of physical chemistry. A 20070419

• Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.

  Diabetes research and clinical practice 20070401

• Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.

  Ophthalmology 20070401

• Arrhythmias associated with fluoroquinolone therapy.

  International journal of antimicrobial agents 20070401

• Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070401

• Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.

  The Journal of antimicrobial chemotherapy 20070401

• Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.

  Journal of chemotherapy (Florence, Italy) 20070401

• Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.

  Current eye research 20070401

• The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy.

  Journal of refractive surgery (Thorofare, N.J. : 1995) 20070401

• Treatment of ankylosing spondylitis with moxifloxacin.

  Southern medical journal 20070401

• Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates.

  European journal of medical research 20070326

• Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.

  Veterinary journal (London, England : 1997) 20070301

• Concentration of moxifloxacin in serum and human aqueous humor following a single 400 mg oral dose.

  Journal of cataract and refractive surgery 20070301

• Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.

  Diagnostic microbiology and infectious disease 20070301

• Thorough QT study with recommended and supratherapeutic doses of tolterodine.

  Clinical pharmacology and therapeutics 20070301

• QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.

  Journal of cardiovascular pharmacology 20070301

• Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.

  Antimicrobial agents and chemotherapy 20070201

• Influence of structural factors on the enhanced activity of moxifloxacin: a fluorescence and EPR spectroscopic study.

  Analytical and bioanalytical chemistry 20070201

• parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones.

  International journal of antimicrobial agents 20070201

• In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.

  Cornea 20070201

• A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment.

  Cornea 20070201

• Vitreal penetration of oral and topical moxifloxacin in humans.

  American journal of ophthalmology 20070201

• Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain.

  Infection control and hospital epidemiology 20070201

• Dysglycemia and fluoroquinolones: are you putting patients at risk?

  The Journal of family practice 20070201

• Moxifloxacin and torsade de pointes.

  The Annals of pharmacotherapy 20070201

• Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects.

  Journal of chemotherapy (Florence, Italy) 20070201

• [In-vitro and in-vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae].

  Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20070201

• Pneumopericardium masquerading as an acute myocardial infarction.

  International journal of cardiology 20070118

• Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin.

  Analytica chimica acta 20070116

• High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma.

  Journal of pharmaceutical and biomedical analysis 20070104

• Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.

  American journal of physiology. Lung cellular and molecular physiology 20070101

• Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.

  The Journal of antimicrobial chemotherapy 20070101

• Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.

  Journal of pharmacological and toxicological methods 20070101

• Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20070101

• Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.

  International journal of antimicrobial agents 20070101

• Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.

  Journal of cataract and refractive surgery 20070101

• Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients.

  Journal of cataract and refractive surgery 20070101

• Moxifloxacin-induced arthropathy.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20070101

• Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.

  Clinical drug investigation 20070101

• [Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].

  Archivos de bronconeumologia 20070101

• Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.

  Drugs in R&D 20070101

• Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis.

  American journal of otolaryngology 20070101

• Methicillin-resistant Staphylococcus aureus caruncle abscess.

  Ophthalmic plastic and reconstructive surgery 20070101

• Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro.

  American journal of rhinology 20070101

• [Nongonococcal urethritis treatment in men with avelox (moxifloxacin)].

  Urologiia (Moscow, Russia : 1999) 20070101

• Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

  Wiener klinische Wochenschrift 20070101

• Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection.

  Arquivos brasileiros de oftalmologia 20070101

• High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial.

  Wiener klinische Wochenschrift 20070101

• A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.

  Journal of pharmacological and toxicological methods 20070101

• Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.

  Journal of pharmacological and toxicological methods 20070101

• [Avelox efficacy in the treatment of acute purulent rhinosinusitis].

  Terapevticheskii arkhiv 20070101

• [Pulmonary fibrosis induced by amiodarone--a pitfall of antiarrhytmic treatment].

  Pneumologia (Bucharest, Romania) 20070101

• Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies.

  Advances in therapy 20070101

• The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.

  The Journal of international medical research 20070101

• Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report.

  Journal of medical case reports 20070101

• [Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes].

  Medycyna doswiadczalna i mikrobiologia 20070101

• [Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20070101

• Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

  Sexually transmitted infections 20061201

• High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.

  The Journal of antimicrobial chemotherapy 20061201

• In vitro development of resistance to DX-619 and other quinolones in enterococci.

  The Journal of antimicrobial chemotherapy 20061201

• No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.

  British journal of pharmacology 20061201

• Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty.

  Journal of cataract and refractive surgery 20061201

• Stability indicating methods for the determination of some fluoroquinolones in the presence of their decarboxylated degrades.

  Chemical & pharmaceutical bulletin 20061201

• Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20061201

• In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.

  Ocular immunology and inflammation 20061201

• Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).

  Journal of clinical pharmacy and therapeutics 20061201

• Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies.

  Clinical cardiology 20061201

• [Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].

  Enfermedades infecciosas y microbiologia clinica 20061201

• Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.

  Journal of chemotherapy (Florence, Italy) 20061201

• The first steps towards fluoroquinolone resistance in Hungarian pneumococci.

  Journal of chemotherapy (Florence, Italy) 20061201

• Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061121

• Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

  Eye (London, England) 20061101

• Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.

  The Journal of antimicrobial chemotherapy 20061101

• Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.

  The Journal of antimicrobial chemotherapy 20061101

• The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy.

  American journal of ophthalmology 20061101

• Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.

  American journal of ophthalmology 20061101

• Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.

  International journal of antimicrobial agents 20061101

• Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.

  Clinical journal of the American Society of Nephrology : CJASN 20061101

• Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.

  British journal of cancer 20061023

• Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.

  Respiratory medicine 20061001

• Moxifloxacin prophylaxis in neutropenic patients.

  The Journal of antimicrobial chemotherapy 20061001

• Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones.

  Journal of cataract and refractive surgery 20061001

• The effect of moxifloxacin on the normal human cornea.

  Current medical research and opinion 20061001

• [Cardiac tolerance of moxifloxacin: Clinical experience from a large observational French study in usual medical practice (IMMEDIAT study)].

  Medecine et maladies infectieuses 20061001

• Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.

  Journal of chemotherapy (Florence, Italy) 20061001

• Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.

  Cornea 20061001

• Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.

  Cornea 20061001

• Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.

  Veterinary journal (London, England : 1997) 20060901

• Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs.

  Respiratory medicine 20060901

• Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.

  Respiratory medicine 20060901

• The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20060901

• Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20060901

• Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.

  The Journal of antimicrobial chemotherapy 20060901

• Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study.

  International journal of antimicrobial agents 20060901

• Intracranial Nocardia recurrence during fluorinated quinolones therapy.

  Transplant infectious disease : an official journal of the Transplantation Society 20060901

• Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060901

• Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.

  Eye & contact lens 20060901

• Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.

  American journal of respiratory and critical care medicine 20060801

• A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.

  The Journal of antimicrobial chemotherapy 20060801

• Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.

  Annals of surgery 20060801

• Permeability of pig urinary bladder wall: time and concentration dependent effect of chitosan.

  Biological & pharmaceutical bulletin 20060801

• Moxifloxacinium chloride-water-methanol (2/1/1), a novel antibacterial agent.

  Acta crystallographica. Section C, Crystal structure communications 20060801

• Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.

  Infection 20060801

• In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060801

• Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20060801

• Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060801

• Application of two methods to determine killing of Streptococcus pneumoniae by various fluoroquinolones.

  Journal of chemotherapy (Florence, Italy) 20060801

• Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20060801

• Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.

  Cornea 20060801

• Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.

  American journal of respiratory and critical care medicine 20060701

• Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability.

  The Journal of pharmacology and experimental therapeutics 20060701

• Treatment of hospitalized patients with community-acquired pneumonia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701

• Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701

• Azithromycin failure in Mycoplasma genitalium urethritis.

  Emerging infectious diseases 20060701

• Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea.

  Eye & contact lens 20060701

• Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies.

  Journal of pharmaceutical and biomedical analysis 20060616

• Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.

  Ophthalmology 20060601

• Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection.

  Analytical biochemistry 20060601

• Man versus machine: is there an optimal method for QT measurements in thorough QT studies?

  Journal of clinical pharmacology 20060601

• Controversies in antibiotic choices for odontogenic infections.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060601

• Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20060601

• Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.

  The Journal of antimicrobial chemotherapy 20060501

• [Pathogenesis, diagnosis and therapy of Legionella infections].

  Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.

  International journal of antimicrobial agents 20060501

• Treatment of implant-associated infections with moxifloxacin: an animal study.

  International journal of antimicrobial agents 20060501

• Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060501

• Phakic status affects vitreous penetration of topical moxifloxacin.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20060501

• Vigamox: how good is its self-preservation?

  Journal of cataract and refractive surgery 20060501

• First successful treatment of Nocardia farcinica brain abscess with moxifloxacin.

  The Journal of infection 20060401

• Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin.

  British journal of pharmacology 20060401

• Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.

  The Journal of antimicrobial chemotherapy 20060401

• Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.

  International journal of antimicrobial agents 20060401

• Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.

  American journal of ophthalmology 20060401

• Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.

  Investigative ophthalmology & visual science 20060401

• Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.

  Journal of chromatographic science 20060401

• Hydrophilic acrylic intraocular lens as a drug-delivery system: Pilot study.

  Journal of cataract and refractive surgery 20060401

• Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.

  Acta orthopaedica 20060401

• Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method.

  International journal of pharmaceutics 20060327

• Glucose homeostasis abnormalities and gatifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060315

• Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.

  AAPS PharmSciTech 20060301

• Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.

  Journal of cataract and refractive surgery 20060301

• Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus.

  The Journal of antimicrobial chemotherapy 20060201

• Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.

  Cornea 20060201

• Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.

  Helicobacter 20060201

• Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges.

  Current medical research and opinion 20060201

• Intravitreal toxicity of moxifloxacin.

  Retina (Philadelphia, Pa.) 20060201

• Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.

  Retina (Philadelphia, Pa.) 20060201

• Vitreous and aqueous penetration of orally administered moxifloxacin in humans.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20060201

• [Rhinosinusitis: etiopathogenesis and antimicrobial therapy, an update].

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20060201

• [Cervical spondylodiscitis: one pathogen may hide another].

  Medecine et maladies infectieuses 20060101

• Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101

• [Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004].

  Medecine et maladies infectieuses 20060101

• Clearance of intravitreal moxifloxacin.

  Investigative ophthalmology & visual science 20060101

• T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.

  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20060101

• Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.

  Current eye research 20060101

• Effects of three fluoroquinolones on QT analysis after standard treatment courses.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101

• The pediatrician's dilemma.

  Journal of pediatric ophthalmology and strabismus 20060101

• Controlling contagious bacterial conjunctivitis.

  Journal of pediatric ophthalmology and strabismus 20060101

• Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis.

  Clinical pharmacokinetics 20060101

• Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.

  Microbial drug resistance (Larchmont, N.Y.) 20060101

• Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation.

  Journal of pharmacological and toxicological methods 20060101

• Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods.

  Chemotherapy 20060101

• A preoperative mixture of anesthetic jelly, dilating drops, antibiotics, and anti-inflammatories for cataract surgery.

  Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20060101

• In vitro activity of fluoroquinolones against common respiratory pathogens.

  The West Indian medical journal 20060101

• Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

  Survey of ophthalmology 20060101

• Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.

  Scandinavian journal of infectious diseases 20060101

• Evidence-based review of moxifloxacin.

  International ophthalmology clinics 20060101

• Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101

• Efficacy and tolerability of moxifloxacin in patients with respiratory tract infections treated in general practice: Results of a post-marketing surveillance study.

  Clinical drug investigation 20060101

• Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.

  Clinical drug investigation 20060101

• [Efficacy of moxifloxacin in the treatment of secondary peritonitis].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20060101

• [Moxifloxacin clinical and microbiological efficacy in therapy of infectious endocarditis].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• [Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101

• Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215

• Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.

  American journal of respiratory and critical care medicine 20051201

• Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.

  American journal of respiratory and critical care medicine 20051201

• Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.

  The Journal of antimicrobial chemotherapy 20051201

• Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.

  The Journal of antimicrobial chemotherapy 20051201

• In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.

  The Journal of antimicrobial chemotherapy 20051201

• Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.

  The Journal of antimicrobial chemotherapy 20051201

• Hopkins scientist tunes in to treat tuberculosis.

  The Journal of clinical investigation 20051201

• Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20051201

• Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations.

  Infection 20051201

• The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.

  Infection 20051201

• Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model.

  Infection 20051201

• Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro.

  Infection 20051201

• Intravitreal clearance of moxifloxacin.

  Transactions of the American Ophthalmological Society 20051201

• QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome.

  British journal of pharmacology 20051101

• Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients.

  The Journal of antimicrobial chemotherapy 20051101

• Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.

  Ophthalmology 20051101

• Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.

  The Journal of antimicrobial chemotherapy 20051101

• Glucose homeostasis abnormalities associated with use of gatifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101

• Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.

  International journal of antimicrobial agents 20051101

• Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor.

  Cornea 20051101

• Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.

  International journal of antimicrobial agents 20051101

• Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.

  International journal of clinical practice 20051101

• Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002).

  Diagnostic microbiology and infectious disease 20051101

• Ophthalmic infections and their anti-infective challenges.

  Survey of ophthalmology 20051101

• In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.

  Survey of ophthalmology 20051101

• Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.

  Survey of ophthalmology 20051101

• Safety of moxifloxacin as shown in animal and in vitro studies.

  Survey of ophthalmology 20051101

• Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis.

  Survey of ophthalmology 20051101

• Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

  Survey of ophthalmology 20051101

• Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

  Survey of ophthalmology 20051101

• Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only?

  The American journal of tropical medicine and hygiene 20051101

• A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.

  Chest 20051101

• Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.

  Journal of cataract and refractive surgery 20051101

• Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.

  Journal of cataract and refractive surgery 20051101

• The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.

  Cornea 20051001

• Cost analyses of community-acquired pneumonia from the hospital perspective.

  Chest 20051001

• Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation.

  Journal of cataract and refractive surgery 20051001

• [The basic and clinical studies of moxifloxacin: the profile as respiratory quinolones].

  The Japanese journal of antibiotics 20051001

• In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.

  The Medical journal of Malaysia 20051001

• Differential effects of three antibiotics on T helper cell cytokine expression.

  The Journal of antimicrobial chemotherapy 20050901

• Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050901

• Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.

  American journal of ophthalmology 20050901

• The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050901

• Empirical antimicrobial therapy for odontogenic infections.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20050901

• Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.

  Alimentary pharmacology & therapeutics 20050901

• Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20050901

• In-use study of potential bacterial contamination of ophthalmic moxifloxacin.

  Journal of cataract and refractive surgery 20050901

• Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

  Respiratory medicine 20050801

• Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro.

  The Journal of antimicrobial chemotherapy 20050801

• Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures.

  Journal of medical microbiology 20050801

• Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration.

  Journal of veterinary pharmacology and therapeutics 20050801

• Influence of human ascitic fluid on the in vitro antibacterial activity of moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20050801

• Acute interstitial nephritis associated with moxifloxacin use.

  Clinical therapeutics 20050801

• Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715

• Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model.

  The Journal of antimicrobial chemotherapy 20050701

• Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.

  The Journal of antimicrobial chemotherapy 20050701

• The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy.

  American journal of ophthalmology 20050701

• Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.

  Cancer 20050615

• Prophylactic use of moxifloxacin in patients receiving bone marrow transplants was not associated with increased ciprofloxacin resistance in Escherichia coli and enterococci.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050615

• Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20050601

• In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.

  The Journal of antimicrobial chemotherapy 20050601

• A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates.

  International journal of antimicrobial agents 20050601

• Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.

  The Journal of urology 20050601

• Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003.

  International journal of antimicrobial agents 20050601

• Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis.

  Journal of pharmaceutical and biomedical analysis 20050601

• Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction.

  Pharmacotherapy 20050601

• Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050601

• Effects of moxifloxacin on QT interval in conscious dogs.

  Journal of veterinary pharmacology and therapeutics 20050601

• A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050601

• [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050601

• Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.

  Alimentary pharmacology & therapeutics 20050515

• Vibrational spectroscopic characterization of fluoroquinolones.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050501

• Penetration of moxifloxacin into the human aqueous humour after oral administration.

  The British journal of ophthalmology 20050501

• Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.

  British journal of clinical pharmacology 20050501

• Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050501

• The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae.

  Critical care medicine 20050501

• Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.

  The Journal of antimicrobial chemotherapy 20050401

• Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection.

  The Journal of antimicrobial chemotherapy 20050401

• Individual QT-R-R relationship: average stability over time does not rule out an individual residual variability: implication for the assessment of drug effect on the QT interval.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20050401

• Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050401

• Clinical assessment of drug-induced QT prolongation in association with heart rate changes.

  Clinical pharmacology and therapeutics 20050401

• In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.

  Journal of chemotherapy (Florence, Italy) 20050401

• In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.

  Journal of chemotherapy (Florence, Italy) 20050401

• Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line.

  The Journal of antimicrobial chemotherapy 20050301

• Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model.

  The Tohoku journal of experimental medicine 20050301

• Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.

  Cornea 20050301

• Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.

  Ophthalmology 20050301

• [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].

  Enfermedades infecciosas y microbiologia clinica 20050301

• Protonation equilibrium and lipophilicity of moxifloxacin.

  Journal of pharmaceutical and biomedical analysis 20050223

• Moxifloxacin-warfarin interaction: a series of five case reports.

  The Annals of pharmacotherapy 20050201

• In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.

  International journal of antimicrobial agents 20050201

• [Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050201

• Moxifloxacin in respiratory tract infections.

  Expert opinion on pharmacotherapy 20050201

• Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.

  The Journal of antimicrobial chemotherapy 20050101

• Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols.

  Cornea 20050101

• Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20050101

• [Tendinitis in the Achilles in the elderly].

  Atencion primaria 20050101

• Tolerability of moxifloxacin in patients with antibiotic hypersensitivity.

  Allergologia et immunopathologia 20050101

• Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials.

  Drug safety 20050101

• Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.

  Current medical research and opinion 20050101

• [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].

  Problemy tuberkuleza i boleznei legkikh 20050101

• Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis.

  Heart & lung : the journal of critical care 20050101

• Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity.

  Journal of investigational allergology & clinical immunology 20050101

• Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.

  Clinical pharmacokinetics 20050101

• Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model.

  Arzneimittel-Forschung 20050101

• Biological assay and liquid chromatographic method for analysis of moxifloxacin in tablets.

  Journal of AOAC International 20050101

• Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis.

  Neurocritical care 20050101

• [Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico].

  Gaceta medica de Mexico 20050101

• Cure of Q fever pneumonia with moxifloxacin: case report.

  Scandinavian journal of infectious diseases 20050101

• [Efficacy of moxifloxacin in the treatment of respiratory tract infections: the Croatian post-marketing study].

  Lijecnicki vjesnik 20050101

• [Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20050101

• Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections.

  The Journal of antimicrobial chemotherapy 20041201

• Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.

  Archives of dermatology 20041201

• Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.

  Transactions of the American Ophthalmological Society 20041201

• Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.

  American journal of respiratory and critical care medicine 20041115

• [Antibiotic therapy of respiratory tract infections. Rapid and good effectiveness].

  MMW Fortschritte der Medizin 20041111

• [Moxifloxacin in general practice. Economical concept].

  MMW Fortschritte der Medizin 20041111

• Impact of plasma protein binding on antimicrobial activity using time-killing curves.

  The Journal of antimicrobial chemotherapy 20041101

• Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis.

  The Journal of infection 20041101

• Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.

  The Journal of infectious diseases 20041101

• Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.

  The Journal of emergency medicine 20041101

• Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.

  Chemotherapy 20041101

• A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.

  Current medical research and opinion 20041101

• MOSAIC acronym.

  Chest 20041101

• [Role of moxifloxacin in the treatment of community-acquired pneumonia].

  Orvosi hetilap 20041031

• [After stroke threatens pneumonia. Antibiotics to be given prophylactically?].

  MMW Fortschritte der Medizin 20041028

• [New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].

  Nederlands tijdschrift voor geneeskunde 20041023

• Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015

• Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.

  The Journal of infectious diseases 20041015

• In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.

  Oral microbiology and immunology 20041001

• Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.

  The Journal of antimicrobial chemotherapy 20041001

• Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials.

  International journal of antimicrobial agents 20041001

• Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.

  Journal of cataract and refractive surgery 20041001

• The effect of cataract surgery on ocular levels of topical moxifloxacin.

  American journal of ophthalmology 20041001

• Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study.

  Journal of periodontology 20041001

• Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.

  International journal of clinical practice 20041001

• Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20041001

• In vitro activity of moxifloxacin against community respiratory pathogens in Qatar.

  International journal of antimicrobial agents 20040901

• SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.

  Antimicrobial agents and chemotherapy 20040901

• Penetration of newer quinolones in the empyema fluid.

  The European respiratory journal 20040901

• What is a MOSAIC study?

  Chest 20040901

• Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20040901

• In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains.

  The Journal of antimicrobial chemotherapy 20040801

• Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections.

  Current opinion in ophthalmology 20040801

• Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers.

  International journal of antimicrobial agents 20040801

• Moxifloxacin--a new fluoroquinolone antibacterial.

  Drug and therapeutics bulletin 20040801

• Evaluation of moxifloxacin activity in vitro against Mycobacterium tuberculosis, including resistant and multidrug-resistant strains.

  Journal of chemotherapy (Florence, Italy) 20040801

• Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.

  Annals of hematology 20040701

• Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20040701

• Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria.

  The Journal of antimicrobial chemotherapy 20040701

• Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects.

  Journal of clinical pharmacology 20040701

• Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.

  American journal of ophthalmology 20040701

• [Acute and bilateral uveitis secondary to moxifloxacin].

  Archivos de la Sociedad Espanola de Oftalmologia 20040701

• Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies.

  Clinical therapeutics 20040701

• Evaluation of vardenafil and sildenafil on cardiac repolarization.

  The American journal of cardiology 20040601

• New real-time PCR-based method for in vitro susceptibility testing of Anaplasma phagocytophilum against antimicrobial agents.

  International journal of antimicrobial agents 20040601

• Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.

  Chemotherapy 20040601

• Moxifloxacin and biofilm production by coagulase-negative staphylococci.

  Chemotherapy 20040601

• Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040515

• Clinical experience with moxifloxacin in patients with respiratory tract infections.

  The Annals of pharmacotherapy 20040501

• Moxifloxacin penetration into human gastrointestinal tissues.

  The Journal of antimicrobial chemotherapy 20040501

• Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study.

  Journal of clinical periodontology 20040501

• Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.

  International journal of antimicrobial agents 20040501

• Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.

  Current eye research 20040501

• Photophysical and phototoxic properties of the antibacterial fluoroquinolones levofloxacin and moxifloxacin.

  Chemistry & biodiversity 20040501

• Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040401

• Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens.

  Diagnostic microbiology and infectious disease 20040401

• Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections.

  Chemotherapy 20040401

• Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar).

  The Medical letter on drugs and therapeutics 20040329

• Structural identification and characterization of impurities in moxifloxacin.

  Journal of pharmaceutical and biomedical analysis 20040310

• [Gigantic study planned. 100,000 patients with COPD test general practice antibiotic].

  MMW Fortschritte der Medizin 20040304

• Voltammetric behaviour and determination of moxifloxacin in pharmaceutical products and human plasma.

  Analytical and bioanalytical chemistry 20040301

• Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

  Antimicrobial agents and chemotherapy 20040301

• No more equivalence trials for antibiotics in exacerbations of COPD, please.

  Chest 20040301

• Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.

  Chest 20040301

• Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.

  Chest 20040301

• Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.

  Diagnostic microbiology and infectious disease 20040301

• Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.

  Survey of ophthalmology 20040301

• In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome.

  European journal of pharmacology 20040220

• Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.

  American journal of respiratory and critical care medicine 20040201

• Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.

  The Journal of antimicrobial chemotherapy 20040201

• Pharmacologic considerations for cataract surgery.

  Current opinion in ophthalmology 20040201

• Sinus tissue concentration of moxifloxacin after a single oral dose.

  The Annals of otology, rhinology, and laryngology 20040201

• Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.

  Journal of veterinary pharmacology and therapeutics 20040201

• Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.

  International journal of antimicrobial agents 20040201

• Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis.

  Clinical therapeutics 20040201

• Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.

  Journal of chemotherapy (Florence, Italy) 20040201

• Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.

  Stroke 20040101

• Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects.

  International journal of clinical pharmacology and therapeutics 20040101

• Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections.

  JPMA. The Journal of the Pakistan Medical Association 20040101

• Recurrent tendinitis after treatment with two different fluoroquinolones.

  Scandinavian journal of infectious diseases 20040101

• Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.

  Drug safety 20040101

• [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101

• Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.

  Scandinavian journal of infectious diseases 20040101

• Moxifloxacin: a review of its use in the management of bacterial infections.

  Drugs 20040101

• Symptom resolution in patients with Mycoplasma pneumoniae pneumonia.

  Canadian respiratory journal 20040101

• [Optimization of tuberculosis complex chemotherapy with the use of moxifloxacin].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101

• Recently introduced antibiotics: a guide for the general physician.

  Clinical medicine (London, England) 20040101

• [Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].

  Likars'ka sprava 20040101

• The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

  American journal of respiratory and critical care medicine 20031201

• Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions.

  International journal of antimicrobial agents 20031201

• In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.

  Diagnostic microbiology and infectious disease 20031201

• Morphostructural damage and the inhibition of bacterial adhesiveness of Staphylococcus aureus and Moraxella catarrhalis induced by moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20031201

• Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.

  Journal of chemotherapy (Florence, Italy) 20031201

• Serum bactericidal activity of the methoxyfluoroquinolones gatifloxacin and moxifloxacin against clinical isolates of Staphylococcus species: are the susceptibility breakpoints too high?

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031115

• Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031101

• Moxifloxacin-induced Clostridium difficile-associated diarrhea.

  Pharmacotherapy 20031101

• Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection.

  Life sciences 20031010

• [Acute exacerbated chronic bronchitis. Antibiotics in comparison].

  MMW Fortschritte der Medizin 20031002

• Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii.

  The Journal of antimicrobial chemotherapy 20031001

• Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20031001

• Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.

  The Journal of antimicrobial chemotherapy 20031001

• Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae.

  The Journal of infectious diseases 20031001

• In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.

  Diagnostic microbiology and infectious disease 20031001

• Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.

  Clinical pharmacology and therapeutics 20031001

• Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.

  Respiratory medicine 20031001

• In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20031001

• Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity.

  Expert review of anti-infective therapy 20031001

• Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk.

  European journal of pharmacology 20030905

• Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.

  American journal of ophthalmology 20030901

• [A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial].

  Archivos de bronconeumologia 20030901

• Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.

  Antimicrobial agents and chemotherapy 20030801

• An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.

  Chest 20030801

• In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.

  International journal of antimicrobial agents 20030701

• A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function.

  Pharmacotherapy 20030701

• The penetration of moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis.

  Chemotherapy 20030701

• Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.

  Chemotherapy 20030701

• In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030701

• Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.

  Circulation 20030617

• Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.

  The Journal of infectious diseases 20030615

• Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20030601

• Immunomodulatory effects of quinolones.

  The Lancet. Infectious diseases 20030601

• In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.

  International journal of antimicrobial agents 20030601

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030601

• Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030601

• Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.

  Journal of chemotherapy (Florence, Italy) 20030601

• Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae.

  Chemotherapy 20030501

• National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents.

  Journal of clinical pathology 20030501

• [Playing it safe in bronchopulmonary infections].

  MMW Fortschritte der Medizin 20030501

• Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.

  The Journal of antimicrobial chemotherapy 20030401

• AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.

  The Journal of antimicrobial chemotherapy 20030401

• Effects of three fluoroquinolones on QT interval in healthy adults after single doses.

  Clinical pharmacology and therapeutics 20030401

• Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.

  The Journal of antimicrobial chemotherapy 20030301

• Experimental pneumococcal pleural empyema model: the effect of moxifloxacin.

  The Journal of antimicrobial chemotherapy 20030301

• [Pneumococcus and quinolone resistance].

  Archivos de bronconeumologia 20030301

• Moxifloxacin-induced Clostridium difficile diarrhea.

  The Annals of pharmacotherapy 20030301

• [New antibiotics in primary care].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030301

• Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results.

  Journal of chemotherapy (Florence, Italy) 20030201

• Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.

  Antimicrobial agents and chemotherapy 20030101

• Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.

  Antimicrobial agents and chemotherapy 20030101

• Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia.

  The European respiratory journal 20030101

• Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.

  The Journal of laryngology and otology 20030101

• [Experience in using the new drug moxifloxacin (Avelox, 'Bayer', Germaniia) in urologic practice].

  Urologiia (Moscow, Russia : 1999) 20030101

• [New approaches to antibacterial therapy of infections in the surgical practice].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101

• Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection.

  Scandinavian journal of infectious diseases 20030101

• Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications.

  The Journal of international medical research 20030101

• Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.

  Advances in therapy 20030101

• Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections.

  International journal of antimicrobial agents 20021201

• In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.

  International journal of antimicrobial agents 20021201

• Moxifloxacin: new preparation. A me-too with more cardiac risks.

  Prescrire international 20021201

• In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.

  Journal of Korean medical science 20021201

• Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).

  Journal of chemotherapy (Florence, Italy) 20021201

• [In vitro activity of moxifloxacin against respiratory pathogens in Latin America].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201

• Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20021107

• Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.

  International journal of antimicrobial agents 20021101

• [Respiratory tract infections. Increasingly more established antibiotics fail].

  MMW Fortschritte der Medizin 20021017

• Simultaneous drug allergies.

  Allergy 20021001

• AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin.

  The Journal of antimicrobial chemotherapy 20021001

• Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20021001

• Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing.

  Archives of internal medicine 20020923

• Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020901

• The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.

  Chest 20020901

• In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.

  International journal of antimicrobial agents 20020901

• Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin.

  International journal of antimicrobial agents 20020901

• In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.

  Diagnostic microbiology and infectious disease 20020801

• Calculation of composite recovery time: a new pharmacodynamic parameter.

  The Journal of antimicrobial chemotherapy 20020801

• Influence of moxifloxacin, comparator drugs and some fractions of pulmonary surfactant on adherence of some respiratory pathogens.

  Infection 20020801

• Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.

  International journal of antimicrobial agents 20020801

• Moxifloxacin-induced acute liver injury.

  The American journal of gastroenterology 20020701

• Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.

  Antimicrobial agents and chemotherapy 20020601

• Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020601

• 'There's no such thing as a free meal'.

  Connecticut medicine 20020601

• Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes.

  The Journal of infectious diseases 20020501

• A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus.

  The Journal of antimicrobial chemotherapy 20020501

• In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 20020401

• Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.

  American journal of ophthalmology 20020401

• Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.

  The Journal of infection 20020401

• Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction.

  British journal of clinical pharmacology 20020301

• Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.

  Alimentary pharmacology & therapeutics 20020301

• Avelox. Respiratory antibiotic now in i.v. form.

  Nursing 20020301

• In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301

• Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.

  International journal of antimicrobial agents 20020201

• Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom.

  Journal of chemotherapy (Florence, Italy) 20020201

• Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae.

  Journal of chemotherapy (Florence, Italy) 20020201

• Improving care for patients with respiratory tract infections.

  Journal of chemotherapy (Florence, Italy) 20020201

• An updated safety profile of moxifloxacin.

  Journal of chemotherapy (Florence, Italy) 20020201

• Susceptibility to moxifloxacin and other antimicrobial agents of major pathogens responsible for community acquired respiratory tract infection in Poland.

  International journal of antimicrobial agents 20020101

• The role of fluoroquinolones in skin and skin structure infections.

  American journal of clinical dermatology 20020101

• Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020101

• E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020101

• Moxifloxacin in uncomplicated skin and skin structure infections.

  Drugs 20020101

• [Perspectives of use of moxifloxacin for treatment of urogenital infections].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• Anaphylactoid reaction caused by moxifloxacin.

  Journal of investigational allergology & clinical immunology 20020101

• [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• [Use of avelox in treating urogenital infections in men].

  Urologiia (Moscow, Russia : 1999) 20020101

• Demonstration of in vitro antagonism between fusidic acid and quinolones.

  The Journal of international medical research 20020101

• [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].

  Vestnik otorinolaringologii 20020101

• Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.

  Scandinavian journal of infectious diseases 20020101

• Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters.

  Chemotherapy 20020101

• [Moxifloxacin: results of clinical use].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101

• Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.

  Antimicrobial agents and chemotherapy 20011201

• Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.

  The Journal of antimicrobial chemotherapy 20011201

• Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin.

  Journal of cataract and refractive surgery 20011201

• Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.

  Pharmacotherapy 20011201

• [Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201

• [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].

  Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201

• Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.

  Antimicrobial agents and chemotherapy 20011101

• [The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community].

  Harefuah 20011101

• In vitro activity of moxifloxacin against local bacterial isolates.

  Annals of the Academy of Medicine, Singapore 20011101

• Moxifloxacin does increase the corrected QT interval.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011015

• Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.

  International journal of antimicrobial agents 20011001

• Moxifloxacin (Avelox) for the treatment of bacterial skin infections.

  Skin therapy letter 20011001

• [Third and fourth generation fluoroquinolones].

  Revue medicale de Bruxelles 20011001

• Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20011001

• Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010901

• Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010901

• The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.

  International journal of clinical practice 20010901

• In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.

  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20010901

• Treatment of Staphylococcus aureus endocarditis using moxifloxacin.

  International journal of medical microbiology : IJMM 20010801

• [Hypertensive crisis and transitory left brunch block with QT interval prolongation associated to moxifloxacin].

  Medicina clinica 20010707

• Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain.

  The Journal of antimicrobial chemotherapy 20010701

• The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.

  Respiratory medicine 20010701

• Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

  International journal of antimicrobial agents 20010701

• Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010701

• Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010601

• Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.

  The Journal of antimicrobial chemotherapy 20010601

• Conventional dogma applied to quinolones? Time for a change.

  The Journal of antimicrobial chemotherapy 20010601

• A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.

  Journal of medical microbiology 20010601

• Microbial drug resistance and the roles of the new antibiotics.

  Cleveland Clinic journal of medicine 20010601

• Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.

  International journal of clinical practice 20010601

• The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.

  Journal of cardiovascular pharmacology 20010501

• Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance.

  International journal of antimicrobial agents 20010501

• Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.

  European journal of haematology 20010501

• A whole blood bactericidal assay for tuberculosis.

  The Journal of infectious diseases 20010415

• Determination of moxifloxacin in growth media by high-performance liquid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20010415

• Reassuring safety profile of moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010401

• Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales.

  The Journal of antimicrobial chemotherapy 20010401

• Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States.

  Diagnostic microbiology and infectious disease 20010401

• Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Profile of moxifloxacin drug interactions.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Evaluation of the clinical microbiology profile of moxifloxacin.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Clinical perspectives on new antimicrobials: focus on fluoroquinolones.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315

• Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics.

  The Journal of pharmacology and experimental therapeutics 20010301

• Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography.

  The Journal of antimicrobial chemotherapy 20010301

• Moxifloxacin: clinical efficacy and safety.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010301

• What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents.

  Postgraduate medicine 20010301

• In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.

  International journal of antimicrobial agents 20010301

• Bactericidal activity of moxifloxacin against Staphylococcus aureus.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010301

• Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.

  Diagnostic microbiology and infectious disease 20010301

• [One year moxifloxacin. Still effective in the respiratory tract].

  MMW Fortschritte der Medizin 20010215

• Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.

  Expert opinion on pharmacotherapy 20010201

• Drug Points: tachycardia associated with moxifloxacin.

  BMJ (Clinical research ed.) 20010106

• Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.

  Antimicrobial agents and chemotherapy 20010101

• In vitro development of resistance to three quinolones in Streptococcus pneumoniae.

  Chemotherapy 20010101

• Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.

  Chest 20010101

• Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.

  Chemotherapy 20010101

• In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101

• Bactericidal activity of moxifloxacin against pneumococci.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101

• Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.

  Clinical pharmacokinetics 20010101

• The influence of age and gender on the pharmacokinetics of moxifloxacin.

  Clinical pharmacokinetics 20010101

• Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.

  Clinical pharmacokinetics 20010101

• Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers.

  Clinical pharmacokinetics 20010101

• Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.

  Clinical pharmacokinetics 20010101

• Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.

  Clinical pharmacokinetics 20010101

• Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.

  Clinical pharmacokinetics 20010101

• Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans.

  Clinical pharmacokinetics 20010101

• Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline.

  Clinical pharmacokinetics 20010101

• Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers.

  Clinical pharmacokinetics 20010101

• Chronic obstructive pulmonary disease.

  The Journal of international medical research 20010101

• Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin.

  The Journal of international medical research 20010101

• Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients.

  The Journal of international medical research 20010101

• Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.

  The Journal of international medical research 20010101

• A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.

  The Journal of international medical research 20010101

• In vitro susceptibility study of BMS-284756 against Legionella species.

  Diagnostic microbiology and infectious disease 20010101

• Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.

  Microbial drug resistance (Larchmont, N.Y.) 20010101

• [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].

  Terapevticheskii arkhiv 20010101

• Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.

  The Journal of antimicrobial chemotherapy 20000501

• Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.

  Drugs 20000101

• Activity of moxifloxacin against mycobacteria.

  The Journal of antimicrobial chemotherapy 19990901

• Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis.

  Antimicrobial agents and chemotherapy 19990101

• In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

  Antimicrobial agents and chemotherapy 19980801

• In vitro activity of BAY 12-8039, a new fluoroquinolone.

  Antimicrobial agents and chemotherapy 19970101